![Matthew Balk](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Matthew Balk
Plus aucun poste en cours
Profil
Matthew Balk is the founder of Entero Therapeutics, Inc. Mr. Balk was an Independent Director at Vivakor, Inc. from 2020 to 2023.
Mr. Balk was a Director at Adapti, Inc. from 2024 to 2025.
Balk earned an MBA from The Leonard N Stern School of Business.
Anciens postes connus de Matthew Balk
| Sociétés | Poste | Fin |
|---|---|---|
| ADAPTI, INC. | Directeur/Membre du Conseil | 25/10/2025 |
| VIVAKOR, INC. | Directeur/Membre du Conseil | 16/01/2023 |
| GRIDAI TECHNOLOGIES CORP. | Fondateur | - |
Formation de Matthew Balk
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
12
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Scepter Holdings, Inc.
 Scepter Holdings, Inc. Household/Personal CareConsumer Non-Durables Manufactures and sells consumer packaged goods | Consumer Non-Durables |
Vivakor, Inc.
 Vivakor, Inc. Chemicals: SpecialtyProcess Industries Operates as an asset acquisition company, which acquires technologies and assets in the fields of precious minerals, biotechnology and alternative energy | Process Industries |
The Leonard N Stern School of Business
 The Leonard N Stern School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Entero Therapeutics, Inc.
 Entero Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures non-systemic therapies for the treatment of patients with gastrointestinal diseases | Health Technology |
